TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  GlobeNewswire Inc.

MLTX Investors Have Opportunity to Lead MoonLake Immunotherapeutics Securities Fraud Lawsuit with the Schall Law Firm

GlobeNewswire Inc. Logo GlobeNewswire Inc. • •By The Schall Law Firm
MLTX Investors Have Opportunity to Lead MoonLake Immunotherapeutics Securities Fraud Lawsuit with the Schall Law Firm

The Schall Law Firm is pursuing a securities fraud lawsuit against MoonLake Immunotherapeutics for allegedly misleading investors about its drug candidate sonelokimab, which resulted in a significant stock price drop after disappointing Phase 3 trial results.

Insights
MLTX   negative

Company allegedly made false statements about drug candidate, misled investors, experienced 90% stock value loss after Phase 3 trial results, and is now facing a securities fraud lawsuit